Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €3.89 EUR
Change Today +0.064 / 1.67%
Volume 112.3K
As of 8:43 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

mdxhealth (MDXH) Snapshot

Open
€3.95
Previous Close
€3.82
Day High
€4.00
Day Low
€3.87
52 Week High
02/24/15 - €5.88
52 Week Low
10/16/14 - €3.11
Market Cap
170.9M
Average Volume 10 Days
283.0K
EPS TTM
€-0.44
Shares Outstanding
44.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MDXHEALTH (MDXH)

Related News

No related news articles were found.

mdxhealth (MDXH) Related Businessweek News

No Related Businessweek News Found

mdxhealth (MDXH) Details

MDxHealth SA, a molecular diagnostics company, develops and commercializes epigenetic tests for cancer assessment, and the personalized treatment of patients. Its tests are based on proprietary gene methylation technology and assist physicians with the diagnosis of cancer, prognosis of recurrence risk, and prediction of response to a specific therapy. It focuses on providing molecular diagnostics products that address unmet clinical needs, as well as used in clinical laboratory testing. The company’s lead product is ConfirmMDx, which treats prostate cancer. Its product pipeline includes tests for bladder, kidney, and other urologic cancers. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA on October 2010. MDxHealth SA was founded in 2003 and is headquartered in Herstal, Belgium.

96 Employees
Last Reported Date: 05/1/15
Founded in 2003

mdxhealth (MDXH) Top Compensated Officers

Chief Executive Officer, President and Execut...
Total Annual Compensation: €491.1K
Compensation as of Fiscal Year 2014.

mdxhealth (MDXH) Key Developments

MDxHealth Appoints Philip J. Ginsburg as Chief Medical Officer

MDxHealth SA announced the appointment of Philip J. Ginsburg, MD, as Chief Medical Officer (CMO). Dr. Ginsburg joins the company with over 20 years of commercial medical laboratory and urology experience. In this new role, Dr. Ginsburg will have overall responsibility for clinical strategy, including scientific and clinical affairs. Before joining MDxHealth, Dr. Ginsburg was CMO, at Toma Biosciences, Iris International Inc. and President of Arista. Prior to Iris International, Dr. Ginsburg was Chief Executive Officer, co-founder and CMO of AlliedPath.

MDxHealth Appoints Philip J. Ginsburg M.D. as Chief Medical Officer

MDxHealth SA announced today, the appointment of Philip J. Ginsburg, MD, as Chief Medical Officer (CMO). Dr. Ginsburg joins the company with over 20 years of commercial medical laboratory and urology experience. In this new role, Dr. Ginsburg will have overall responsibility for clinical strategy, including scientific and clinical affairs. Before joining MDxHealth, Dr. Ginsburg was CMO, at Toma Biosciences, Iris International Inc. and President of Arista.

MDxHealth SA Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2015

MDxHealth SA reported unaudited earnings results for the first quarter ended March 31, 2015. Revenue was $4.0 million against $1.9 million last year. LBITDA was $2.6 million against $4.3 million last year. LBIT was $2.8 million against $4.3 million last year. Net loss was $2.5 million against $4.0 million last year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDXH:BB €3.89 EUR +0.064

MDXH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Health Discovery Corp $0.03 USD 0.00
Imperial Innovations Group PLC 497.50 GBp 0.00
Miraculins Inc C$0.06 CAD 0.00
Vermillion Inc $1.90 USD +0.0095
View Industry Companies
 

Industry Analysis

MDXH

Industry Average

Valuation MDXH Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 12.4x
Price/Book 3.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 9.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MDXHEALTH, please visit www.mdxhealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.